© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The agency expressed concerns about the monthly injectable regimen’s chemistry and manufacturing controls.
Here are the HIV treatment news stories with the most views this year.
Long-acting injectables may be given once every other month, according to new findings.
An analysis of 15,000 insured people with HIV also confirmed past findings that single-tablet regimens are associated with higher adherence.
The attachment inhibitor plus an optimized antiretroviral background regimen suppressed HIV in the majority of study participants.
“As Much As I Can” returns with a new format but the same powerful messages.
Recently, ViiV Healthcare applied for approval of the first long-acting injectable HIV regimen.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Who got what and why? NMAC’s Paul Kawata addresses criticism and breaks down the data.
A late-stage trial randomized people taking a stable HIV regimen to switch to Dovato or stay on their current antiretrovirals.
The experimental long-acting injectable regimen of cabotegravir and rilpivirine stands poised for approval.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
